2024-16830. Agency Information Collection Activities; Proposed Collection; Comment Request; Generic Clearance for Quantitative Testing for the Development of Food and Drug Administration Communications  

  • Table 1—Estimated Annual Reporting Burden 1

    Activity Number of respondents Number of responses per respondent Total annual responses Average burden per response Total hours
    Cognitive Interviews Screener 720 1 720 0.083 (5 minutes) 60
    Cognitive Interviews 144 1 144 1 144
    Pre-test study screener 2,400 1 2,400 0.083 (5 minutes) 199
    Pre-testing study 480 1 480 0.25 (15 minutes) 120
    Self-administered surveys/experimental Studies Screener 75,000 1 75,000 0.083 (5 minutes) 6,225
    Self-Administered Surveys/Experimental Studies 15,000 1 15,000 0.25 (15 minutes) 3,750
    Total 10,498
    1  There are no capital costs or operating and maintenance costs associated with this collection of information.

Document Information

Published:
07/31/2024
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2024-16830
Dates:
Either electronic or written comments on the collection of information must be submitted by September 30, 2024.
Pages:
61453-61454 (2 pages)
Docket Numbers:
Docket No. FDA-2024-N-2865
PDF File:
2024-16830.pdf